{"version":"1.0","provider_name":"Pharmacologie clinique et vigilances","provider_url":"https:\/\/www.chu-poitiers.fr\/specialites\/pharmacologie-clinique-vigilances","author_name":"adminchu","author_url":"https:\/\/www.chu-poitiers.fr\/specialites\/pharmacologie-clinique-vigilances\/author\/adminchu\/","title":"Pharmacog\u00e9n\u00e9tique - Pharmacologie clinique et vigilances","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"u3XG06SqaG\"><a href=\"https:\/\/www.chu-poitiers.fr\/specialites\/pharmacologie-clinique-vigilances\/pharmacogenetique\/\">Pharmacog\u00e9n\u00e9tique<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.chu-poitiers.fr\/specialites\/pharmacologie-clinique-vigilances\/pharmacogenetique\/embed\/#?secret=u3XG06SqaG\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Pharmacog\u00e9n\u00e9tique\u00a0\u00bb &#8212; Pharmacologie clinique et vigilances\" data-secret=\"u3XG06SqaG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.chu-poitiers.fr\/specialites\/pharmacologie-clinique-vigilances\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"[vc_row][vc_column][vc_column_text css=\u00a0\u00bb.vc_custom_1678287706456{margin-top: 10px !important;margin-right: 10px !important;margin-bottom: 10px !important;margin-left: 10px !important;padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #ecf2f4 !important;}\u00a0\u00bb] L\u2019unit\u00e9 de pharmacog\u00e9n\u00e9tique propose une activit\u00e9 de g\u00e9notypage afin de pouvoir d\u00e9tecter ou comprendre l\u2019absence de r\u00e9ponse \u00e0 un traitement pharmacologique ou, au contraire, identifier le risque de survenue d\u2019effets ind\u00e9sirables m\u00e9dicamenteux chez certains patients. [&hellip;]"}